Clinical Study
Can Peak Expiratory Flow Measurements Differentiate Chronic Obstructive Pulmonary Disease from Congestive Heart Failure?
Table 1
Patients enrolled in study.
| Age | Predicted peak flow | Measured peak flow | % Predicted | Discharge Dx |
| 64 | 550 | 132 | 24.0% | CHF | 33 | 650 | 420 | 64.6% | CHF | 87 | 402 | 175 | 43.5% | CHF | 66 | 430 | 190 | 44.2% | CHF | 41 | 650 | 370 | 56.9% | CHF | 71 | 552 | 240 | 43.5% | CHF | 71 | 416 | 70 | 16.8% | CHF | 73 | 410 | 325 | 79.3% | CHF | 57 | 605 | 180 | 29.8% | CHF | 59 | 542 | 310 | 57.20% | CHF | 59 | 542 | 310 | 57.20% | CHF | 60 | 591 | 200 | 33.84% | CHF | 65 | 550 | 125 | 22.7% | COPD | 52 | 466 | 225 | 48.3% | COPD | 64 | 572 | 85 | 14.86% | COPD | 55 | 418 | 60 | 14.35% | COPD | 50 | 602 | 240 | 39.87% | COPD | 67 | 554 | 100 | 18.05% | COPD |
|
|